Clinical trials are research studies that study the effectiveness of new treatments. People who join clinical trials are volunteers (also called participants).
Clinical trial participants are key to developing safe treatments that work well to prevent, diagnose and treat kidney disease. The participants in clinical trials should represent the diverse group of people who have the health problem being studied and will use the treatment out in the world.
Black, Hispanic, Native American and Asian American people have a greater chance of having kidney failure compared to white counterparts. To make sure that treatments are safe and work for all people with kidney disease, it is important for clinical trials to include people from diverse backgrounds.
Research has shown that people may have different reactions to treatments based on their race, ethnicity, gender, age and other factors. This is why it is important for clinical trial to include participants of different races, ethnicities, genders, and ages.
Learn more about why diversity in clinical trials is important and consider why you should take part in a clinical trial: [ Ссылка ]
Education content made possible by GSK
